现在是时候使用氟代脱氧葡萄糖正电子发射断层显像/计算机断层扫描（F-FDG PET/CT）来优化三阴性乳腺癌的新辅助治疗了！ - Suppr

Suppr

超能文献

Now Is the Time to Use F-FDG PET/CT to Optimize Neoadjuvant Treatment in Triple-Negative Breast Cancer!

作者信息

Groheux David

机构信息

Nuclear Medicine Department, Saint-Louis Hospital, Paris, France; and

University Paris-Diderot, INSERM/CNRS UMR944/7212, Paris, France.

出版信息

J Nucl Med. 2018 Jun;59(6):863-864. doi: 10.2967/jnumed.118.210922. Epub 2018 Apr 19.

DOI:10.2967/jnumed.118.210922

PMID:29674423

Abstract

摘要

相似文献

Now Is the Time to Use F-FDG PET/CT to Optimize Neoadjuvant Treatment in Triple-Negative Breast Cancer!

J Nucl Med. 2018 Jun;59(6):863-864. doi: 10.2967/jnumed.118.210922. Epub 2018 Apr 19.

Complete Metabolic Response on Interim F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography to Predict Long-Term Survival in Patients with Breast Cancer Undergoing Neoadjuvant Chemotherapy.

Oncologist. 2017 May;22(5):526-534. doi: 10.1634/theoncologist.2016-0334. Epub 2017 Apr 4.

Additional value of F-FDG PET/CT response evaluation in axillary nodes during neoadjuvant therapy for triple-negative and HER2-positive breast cancer.

Cancer Imaging. 2017 May 25;17(1):15. doi: 10.1186/s40644-017-0117-5.

Role of F-PET/CT in Predicting Prognosis of Patients With Breast Cancer After Neoadjuvant Chemotherapy.

Clin Breast Cancer. 2018 Feb;18(1):45-52. doi: 10.1016/j.clbc.2017.09.006. Epub 2017 Sep 19.

Tumor metabolism assessed by FDG-PET/CT and tumor proliferation assessed by genomic grade index to predict response to neoadjuvant chemotherapy in triple negative breast cancer.

Eur J Nucl Med Mol Imaging. 2018 Jul;45(8):1279-1288. doi: 10.1007/s00259-018-3998-z. Epub 2018 Apr 4.

Early assessment with 18F-fluorodeoxyglucose positron emission tomography/computed tomography can help predict the outcome of neoadjuvant chemotherapy in triple negative breast cancer.

Eur J Cancer. 2014 Jul;50(11):1864-71. doi: 10.1016/j.ejca.2014.04.020. Epub 2014 May 16.

18F-FDG PET-Derived Tumor Blood Flow Changes After 1 Cycle of Neoadjuvant Chemotherapy Predicts Outcome in Triple-Negative Breast Cancer.

J Nucl Med. 2016 Nov;57(11):1707-1712. doi: 10.2967/jnumed.116.172759. Epub 2016 Apr 21.

(18)F-FDG-PET/CT for systemic staging of newly diagnosed triple-negative breast cancer.

Eur J Nucl Med Mol Imaging. 2016 Oct;43(11):1937-44. doi: 10.1007/s00259-016-3402-9. Epub 2016 Apr 30.

Prediction of breast cancer recurrence using lymph node metabolic and volumetric parameters from F-FDG PET/CT in operable triple-negative breast cancer.

Eur J Nucl Med Mol Imaging. 2017 Oct;44(11):1787-1795. doi: 10.1007/s00259-017-3748-7. Epub 2017 Jun 14.

A rare case of clear cell carcinoma of the breast evaluated by (18)F-FDG PET/CT.

Rev Esp Med Nucl Imagen Mol. 2015 Jul-Aug;34(4):264-5. doi: 10.1016/j.remn.2014.11.003. Epub 2015 Jan 5.

引用本文的文献

Baseline F-FDG PET/CT for predicting pathological response to neoadjuvant chemotherapy and prognosis in locally advanced breast cancer patients: analysis of tumor and lymphoid organs metabolic parameters.

Radiol Med. 2025 Mar;130(3):422-437. doi: 10.1007/s11547-025-01961-9. Epub 2025 Feb 12.

Negative Relationship between Post-Treatment Stromal Tumor-Infiltrating Lymphocyte (TIL) and Survival in Triple-Negative Breast Cancer Patients Treated with Dose-Dense Dose-Intense NeoAdjuvant Chemotherapy.

Cancers (Basel). 2022 Mar 4;14(5):1331. doi: 10.3390/cancers14051331.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验